Europe, Middle East & Africa
Cenduit Interactive Response Technology
Run faster, higher quality patient-centric studies
Oct 30, 2020
Accelerate study start-up and amendments, simplify site and sponsor experience, reduce trial supply costs and improve study decision making while ensuring quality standards and patient safety during your trial with Cenduit Interactive Response Technology. Built on a robust, scalable platform, our patient-centric approach to technology delivery provides exceptional value and peace of mind for sponsors and their patients in clinical trials. Cenduit IRT is part of the Digital Patient Suite of IQVIA Technologies Orchestrated Clinical Trials (OCT), an end-to-end, patientcentric platform that provides an unparalleled data infrastructure, seamless connectivity and intuitive design to drive smarter, faster trials.
Related Solutions
Interactive Response Technology
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Patient Engagement Suite
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
You may also be interested in